MB097 clinical trials

A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients

This study looks at a new drug, MB097, combined with another treatment, Pembrolizumab, for people with melanoma that hasn't responded to previous therapy. Researchers want to see if this combination is safe and how well people tolerate it.